IRIS
MEDAGLINI, DONATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.243
EU - Europa 9.718
AS - Asia 5.409
SA - Sud America 933
Continente sconosciuto - Info sul continente non disponibili 324
AF - Africa 310
OC - Oceania 22
AN - Antartide 1
Totale 27.960
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.014
RU - Federazione Russa 2.006
IT - Italia 1.939
SG - Singapore 1.736
CN - Cina 1.703
GB - Regno Unito 1.503
IE - Irlanda 1.197
BR - Brasile 748
SE - Svezia 661
VN - Vietnam 589
DE - Germania 578
UA - Ucraina 521
FR - Francia 486
HK - Hong Kong 447
FI - Finlandia 411
KR - Corea 288
ZA - Sudafrica 181
IN - India 163
CA - Canada 126
BD - Bangladesh 124
ES - Italia 75
NL - Olanda 68
PL - Polonia 56
AR - Argentina 55
MX - Messico 48
IQ - Iraq 40
JP - Giappone 40
NG - Nigeria 40
TR - Turchia 40
UZ - Uzbekistan 38
BE - Belgio 33
AT - Austria 32
VE - Venezuela 28
PK - Pakistan 25
ID - Indonesia 24
EC - Ecuador 23
CH - Svizzera 22
CL - Cile 21
CZ - Repubblica Ceca 19
AU - Australia 18
LT - Lituania 18
CI - Costa d'Avorio 17
KE - Kenya 16
CO - Colombia 15
IR - Iran 14
SA - Arabia Saudita 14
EG - Egitto 13
GR - Grecia 13
MA - Marocco 13
MY - Malesia 13
PE - Perù 12
CR - Costa Rica 11
IL - Israele 11
PH - Filippine 11
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
BO - Bolivia 10
JO - Giordania 9
NP - Nepal 9
PT - Portogallo 9
DK - Danimarca 8
DO - Repubblica Dominicana 8
EU - Europa 8
JM - Giamaica 8
UY - Uruguay 8
AZ - Azerbaigian 7
OM - Oman 7
SI - Slovenia 7
ET - Etiopia 6
RS - Serbia 6
TH - Thailandia 6
BG - Bulgaria 5
HN - Honduras 5
MD - Moldavia 5
PA - Panama 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
DZ - Algeria 4
GT - Guatemala 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LB - Libano 4
LK - Sri Lanka 4
MT - Malta 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
TN - Tunisia 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
EE - Estonia 3
GE - Georgia 3
HR - Croazia 3
LV - Lettonia 3
PS - Palestinian Territory 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AO - Angola 2
BB - Barbados 2
Totale 27.602
Salva come PNG Salva come JPEG
Città #
Dallas 1.409
Southend 1.198
Dublin 1.193
Ashburn 947
Singapore 944
Fairfield 889
Chandler 678
Santa Clara 575
Moscow 540
San Jose 456
Milan 455
Hong Kong 420
Jacksonville 417
Beijing 400
Woodbridge 399
Siena 369
Hefei 335
Houston 334
Seattle 332
Council Bluffs 316
Wilmington 312
Cambridge 297
Seoul 280
Ann Arbor 246
Helsinki 219
Los Angeles 209
Princeton 198
Rome 184
Munich 176
New York 165
The Dalles 164
Johannesburg 161
Ho Chi Minh City 138
Nanjing 134
Hanoi 133
Lauterbourg 129
Dong Ket 121
Florence 116
Lappeenranta 73
San Mateo 73
Boardman 71
São Paulo 70
San Diego 66
Buffalo 64
Shanghai 60
Lancaster 59
North Bergen 58
Columbus 57
Orem 54
Shenyang 49
Menlo Park 48
London 47
Frankfurt am Main 44
Nuremberg 43
Nanchang 41
Chicago 40
Turku 40
Montreal 39
Bengaluru 38
Redondo Beach 38
Tokyo 38
Abuja 37
Phoenix 36
Toronto 35
Denver 34
Chennai 33
Brussels 31
Tashkent 31
Dearborn 30
Warsaw 30
Amsterdam 29
Tianjin 28
Málaga 27
San Francisco 27
Washington 27
Düsseldorf 25
Kunming 25
Figino 24
Da Nang 23
Hebei 23
Belo Horizonte 22
Brooklyn 22
Guangzhou 22
Haiphong 22
Jiaxing 22
Fremont 21
Turin 21
Poplar 20
Atlanta 19
Boston 19
Rio de Janeiro 19
Naples 18
Abidjan 17
Norwalk 17
Bologna 16
Changsha 16
Stockholm 16
Dhaka 15
Madrid 15
Messina 15
Totale 18.127
Salva come PNG Salva come JPEG
Nome #
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 369
13C-NMR determination of simultaneous xylose and glucose fermentation by a newly isolated strain (G11) of Klebsiella planticola 344
Vaginal immunization to elicit primary T-cell activation and dissemination 334
Vaccination in the elderly: The challenge of immune changes with aging 325
Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation 323
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 321
A stochastic model for CD4+ T cell proliferation and dissemination network in primary immune response 319
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study 314
Nuovi approci diagnostici nelle infezioni pneumococciche: possibile ruolo della Real-time PCR e dei biomarcatori 306
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 303
Analysis of the utility of a rapid vesicle isolation method for clinical strains of Pseudomonas aeruginosa 298
Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice 298
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 297
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 286
Ebola vaccine R&D: Filling the knowledge gaps 285
Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine 284
Adoptive transfer of transgenic T cells to study mucosal adjuvants 280
Correlates of vaccine-induced protective immunity against Ebola virus disease 279
Identification of a branching process model for adaptive immune response 270
Characterization of the antigen-specific CD4+ T cell response induced by prime-boost strategies with CAF01 and CpG adjuvants administered by the intranasal and subcutaneous routes 268
Role of the microbiota in the modulation of vaccine immune responses 268
Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells 263
Interferon-γ from Brain Leukocytes Enhances Meningitis by Type 4 Streptococcus pneumoniae 263
Big science for vaccine development 255
In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii 251
Assessment of mucosal immunity to HIV-1 249
Optimized protocol for the detection of multifunctional epitope-specific CD4+ T cells combining MHC-II tetramer and intracellular cytokine staining technologies 245
Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols 243
Modulation of Primary Immune Response by Different Vaccine Adjuvants 243
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 236
Biotechnological approaches to fight pathogens at mucosal sites 226
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 224
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 224
Genetic engineering of Streptococcus gordonii for the simultaneous display of two heterologous proteins at the bacterial surface 222
The European research effort for HIV/AIDS, malaria and tuberculosis 219
Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts 216
Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii 216
Valutazione della risposta al test IGRA in pazienti pediatrici contatto di TBC o con sospetto clinico di infezione attiva 213
Transcriptomics of the vaccine immune response: Priming with adjuvant modulates recall innate responses after boosting 212
CD4+ T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines 209
Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii 209
ADITEC: joining forces for next-generation vaccines 209
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 208
Long-term anti-bacterial immunity against systemic infection by Salmonella enterica serovar typhimurium elicited by a GMMA-based vaccine 208
Immunoglobulin-binding domains of peptostreptococcal protein L enhance vaginal colonization of mice by Streptococcus gordonii 206
Recombinant Gram-positive bacteria as vehicles of vaccine antigens 206
Immunization with the conjugate vaccine Vi-CRM(197) against Salmonella Typhi induces Vi-specific mucosal and systemic immune responses in mice 205
Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4(+) and CD8(+) T cells in the genital and intestinal tracts 203
Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. 203
Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine 201
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 200
Vaccine adjuvants: A priority for vaccine research 200
La diagnosi eziologica della polmonite comunitaria: possibile ruolo della Real-Time PCR in una coorte di pazienti adulti e pediatrici 200
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 199
Comparison of Immune Responses Elicited by BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 Vaccines. 197
Spike-Specific memory B cell response in hematopoietic cell transplantation recipients following multiple mRNA-1273 vaccinations: a longitudinal observational study 196
O:2-CRM(197) Conjugates against Salmonella Paratyphi A 196
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability 194
Antibody response and protection from challenge in mice immunized with recombinant Streptococcus gordonii expressing fragment C of tetanus toxin 194
Computational Analysis of Multiparametric Flow Cytometric Data to Dissect B Cell Subsets in Vaccine Studies 193
Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice 191
Complications and mortality of non-typhoidal salmonella invasive disease: a global systematic review and meta-analysis 190
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration 189
Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patients 189
Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii 189
In vivo primary activation of CD4+ and CD8+ T-cells following mucosal vaccination 187
Primary T-cell response to mucosal vaccination 186
Physicochemical characterization cascade of nanoadjuvant–antigen systems for improving vaccines 186
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population 185
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity? 185
The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1 183
Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response 182
From bivariate to multivariate analysis of cytometric data: overview of computational methods and their application in vaccination studies 182
Induzione primaria di linfociti T CD4 nel tessuto linfoide associato al naso (NALT) in seguito ad immunizzazione con Streptococcus gordonii 180
Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice 180
Immunogenicity of a bivalent adjuvanted glycoconjugate vaccine against Salmonella typhimurium and Salmonella Enteritidis 180
CTA1-DD has an Adjuvant Effect Once Expressed on the Surface of the Gram-Positive Bacterium Streptococcus gordonii 179
Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium 178
Impact of interproximal composite restorations on periodontal tissue health: Clinical and cytokine profiles from a pre-post quasi-experimental study 178
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine 178
Gram-positive commensal bacteria for mucosal vaccine delivery. 177
Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge 176
Innate immunity against HIV: a priority target for HIV prevention research 172
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination 172
Surface display of recombinant proteins on Bacillus subtilis spores 170
Human dendritic cells are superior to B cells at presenting a major histocompatibility complex class II-restricted heterologous antigen expressed on recombinant Streptococcus gordonii 170
NMR Investigation of the Simultaneous Fermentation of Xylose and Glucose by a Selected Strain of Klebsiella Planticola (G11) 169
In vivo mucosal delivery of bioactive human interleukin 1 recepor antagonist produced by Streptococcus gordonii 169
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein 167
Vaginal immunization with recombinant gram-positive bacteria 167
The European effort towards the development of mucosal vaccines for poverty-related diseases 166
Immune Memory After Respiratory Infection With Streptococcus pneumoniae Is Revealed by in vitro Stimulation of Murine Splenocytes With Inactivated Pneumococcal Whole Cells: Evidence of Early Recall Responses by Transcriptomic Analysis 165
Ruolo del sierotipo capsulare nella suscettibilità di Streptococcus pneumoniae alla cellula microgliale 165
Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria 165
A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa 164
Incidence of non-typhoidal Salmonella invasive disease: A systematic review and meta-analysis 164
Editorial: Advanced Immunization Technologies for Next Generation Vaccines 163
The slower antibody response in myelofibrosis patients after two doses of MRNA sars-COV-2 vaccine calls for a third dose 163
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses 161
Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens 161
Totale 21.850
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.804
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.804
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.473 0 225 97 159 64 27 85 53 83 142 184 354
2022/20232.352 146 238 317 305 212 463 61 205 181 49 118 57
2023/20242.022 72 67 160 118 79 518 665 65 43 87 35 113
2024/20254.385 129 179 428 248 535 278 204 263 435 180 422 1.084
2025/202610.350 779 1.459 1.038 1.217 1.838 356 1.044 382 473 621 368 775
2026/2027779 493 286 0 0 0 0 0 0 0 0 0 0
Totale 27.960